Texaphyrin conjugates and uses thereof
CA 2334809 A1 · Owner: Sessler, Jonathan L. · Inventors: Carvalho, Joan; Mody, Tarak; Anzenbacher, Pavel Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Texaphyrin/chemotherapeutic drug conjugates optionally including a platinum , (II) or platinum (IV) metal chelating site and/or complex are useful for , treating atheroma, tumors and other neoplastic tissue neovascular-related , diseases, as well as other conditions that are typically responsive to chemotherapy, radiation sensitization and photodynamic therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 4, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 4, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 4, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.